Clinical Trial: A Single- and Multiple-Dose Study of Enlicitide Chloride (MK-0616) in Healthy Chinese Adult Participants (MK 0616-010)

U.S., Feb. 8 -- ClinicalTrials.gov registry received information related to the study (NCT06814106) titled 'A Single- and Multiple-Dose Study of Enlicitide Chloride (MK-0616) in Healthy Chinese Adult Participants (MK 0616-010)' on Feb. 03.

Brief Summary: The purpose of this study is to learn about the safety of enlicitide chloride and how well people tolerate it. Researchers also want to learn what happens to different amounts of enlicitide chloride in a healthy person's body over time.

Study Start Date: March 06, 2023

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: Enlicitide Chloride

Oral Capsule

DRUG: Placebo

Placebo oral capsule matching enlicitide chloride

Recruitment Status: COMPLETED

Sponsor: Merck Sharp...